img

Global and India Hormone Disorder Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Hormone Disorder Drug Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Hormone Disorder Drug Market
This report focuses on global and India Hormone Disorder Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Hormone Disorder Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Hormone Disorder Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Hormone Disorder Drug include Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc. The global five biggest players hold a share of % in 2024.
Global Hormone Disorder Drug Scope and Market Size
Hormone Disorder Drug market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Hormone Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Hormone Disorder Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Teva Pharmaceutical Industries Ltd
Amneal Pharmaceutical Inc
Mayne Pharma Group Limited
Merck KGaA
Sanofi
Sun Pharmaceutical Industries Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Abbott
PT. Daewoong Pharmaceutical Company
Genentech, Inc
Bausch Health Companies Inc
Lilly
Ipsen Pharma
Ferring B.V
Segment by Type
Growth Hormone Stimulator
Growth Hormone Inhibitor

Segment by Application


Dwarfism
Gigantism
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Hormone Disorder Drug definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Hormone Disorder Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Hormone Disorder Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hormone Disorder Drug sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Hormone Disorder Drug Product Introduction
1.2 Global Hormone Disorder Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Hormone Disorder Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global Hormone Disorder Drug Sales in Volume for the Year 2018-2034
1.3 India Hormone Disorder Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India Hormone Disorder Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India Hormone Disorder Drug Sales in Volume for the Year 2018-2034
1.4 Hormone Disorder Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Hormone Disorder Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Hormone Disorder Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Hormone Disorder Drug Market Dynamics
1.5.1 Hormone Disorder Drug Industry Trends
1.5.2 Hormone Disorder Drug Market Drivers
1.5.3 Hormone Disorder Drug Market Challenges
1.5.4 Hormone Disorder Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Hormone Disorder Drug by Type
2.1 Hormone Disorder Drug Market Segment by Type
2.1.1 Growth Hormone Stimulator
2.1.2 Growth Hormone Inhibitor
2.2 Global Hormone Disorder Drug Market Size by Type
2.2.1 Global Hormone Disorder Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Hormone Disorder Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Hormone Disorder Drug Market Size by Type
2.3.1 India Hormone Disorder Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Hormone Disorder Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Hormone Disorder Drug by Application
3.1 Hormone Disorder Drug Market Segment by Application
3.1.1 Dwarfism
3.1.2 Gigantism
3.1.3 Other
3.2 Global Hormone Disorder Drug Market Size by Application
3.2.1 Global Hormone Disorder Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Hormone Disorder Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Hormone Disorder Drug Market Size by Application
3.3.1 India Hormone Disorder Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Hormone Disorder Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Hormone Disorder Drug Competitor Landscape by Company
4.1 Global Hormone Disorder Drug Market Size by Company
4.1.1 Global Key Manufacturers of Hormone Disorder Drug, Ranked by Revenue (2024)
4.1.2 Global Hormone Disorder Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global Hormone Disorder Drug Sales by Manufacturer (2018-2023)
4.1.4 Global Hormone Disorder Drug Price by Manufacturer (2018-2023)
4.2 Global Hormone Disorder Drug Concentration Ratio (CR)
4.2.1 Hormone Disorder Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hormone Disorder Drug in 2024
4.2.3 Global Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hormone Disorder Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hormone Disorder Drug, Product Offered and Application
4.5 Global Key Manufacturers of Hormone Disorder Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Hormone Disorder Drug Market Size by Company
4.7.1 Key Players of Hormone Disorder Drug in India, Ranked by Revenue (2024)
4.7.2 India Hormone Disorder Drug Revenue by Players (2018-2023)
4.7.3 India Hormone Disorder Drug Sales by Players (2018-2023)
5 Global Hormone Disorder Drug Market Size by Region
5.1 Global Hormone Disorder Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Hormone Disorder Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global Hormone Disorder Drug Sales in Volume by Region: 2018-2023
5.2.2 Global Hormone Disorder Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global Hormone Disorder Drug Market Size in Value by Region (2018-2034)
5.3.1 Global Hormone Disorder Drug Sales in Value by Region: 2018-2023
5.3.2 Global Hormone Disorder Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Hormone Disorder Drug Market Size YoY Growth 2018-2034
6.2 Americas Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Hormone Disorder Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Hormone Disorder Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Hormone Disorder Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hormone Disorder Drug Market Size YoY Growth 2018-2034
7.2 EMEA Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Hormone Disorder Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Hormone Disorder Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Hormone Disorder Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hormone Disorder Drug Market Size YoY Growth 2018-2034
8.2 China Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Hormone Disorder Drug Market Size YoY Growth 2018-2034
9.2 APAC Hormone Disorder Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Hormone Disorder Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Hormone Disorder Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Hormone Disorder Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Hormone Disorder Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Company Information
10.1.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
10.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Products Offered
10.1.5 Teva Pharmaceutical Industries Ltd Recent Development
10.2 Amneal Pharmaceutical Inc
10.2.1 Amneal Pharmaceutical Inc Company Information
10.2.2 Amneal Pharmaceutical Inc Description and Business Overview
10.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Products Offered
10.2.5 Amneal Pharmaceutical Inc Recent Development
10.3 Mayne Pharma Group Limited
10.3.1 Mayne Pharma Group Limited Company Information
10.3.2 Mayne Pharma Group Limited Description and Business Overview
10.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Products Offered
10.3.5 Mayne Pharma Group Limited Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Information
10.4.2 Merck KGaA Description and Business Overview
10.4.3 Merck KGaA Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck KGaA Hormone Disorder Drug Products Offered
10.4.5 Merck KGaA Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Description and Business Overview
10.5.3 Sanofi Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Hormone Disorder Drug Products Offered
10.5.5 Sanofi Recent Development
10.6 Sun Pharmaceutical Industries Ltd
10.6.1 Sun Pharmaceutical Industries Ltd Company Information
10.6.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Products Offered
10.6.5 Sun Pharmaceutical Industries Ltd Recent Development
10.7 Novartis AG
10.7.1 Novartis AG Company Information
10.7.2 Novartis AG Description and Business Overview
10.7.3 Novartis AG Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis AG Hormone Disorder Drug Products Offered
10.7.5 Novartis AG Recent Development
10.8 F. Hoffmann-La Roche Ltd
10.8.1 F. Hoffmann-La Roche Ltd Company Information
10.8.2 F. Hoffmann-La Roche Ltd Description and Business Overview
10.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Products Offered
10.8.5 F. Hoffmann-La Roche Ltd Recent Development
10.9 Abbott
10.9.1 Abbott Company Information
10.9.2 Abbott Description and Business Overview
10.9.3 Abbott Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Abbott Hormone Disorder Drug Products Offered
10.9.5 Abbott Recent Development
10.10 PT. Daewoong Pharmaceutical Company
10.10.1 PT. Daewoong Pharmaceutical Company Company Information
10.10.2 PT. Daewoong Pharmaceutical Company Description and Business Overview
10.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Products Offered
10.10.5 PT. Daewoong Pharmaceutical Company Recent Development
10.11 Genentech, Inc
10.11.1 Genentech, Inc Company Information
10.11.2 Genentech, Inc Description and Business Overview
10.11.3 Genentech, Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Genentech, Inc Hormone Disorder Drug Products Offered
10.11.5 Genentech, Inc Recent Development
10.12 Bausch Health Companies Inc
10.12.1 Bausch Health Companies Inc Company Information
10.12.2 Bausch Health Companies Inc Description and Business Overview
10.12.3 Bausch Health Companies Inc Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bausch Health Companies Inc Hormone Disorder Drug Products Offered
10.12.5 Bausch Health Companies Inc Recent Development
10.13 Lilly
10.13.1 Lilly Company Information
10.13.2 Lilly Description and Business Overview
10.13.3 Lilly Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Lilly Hormone Disorder Drug Products Offered
10.13.5 Lilly Recent Development
10.14 Ipsen Pharma
10.14.1 Ipsen Pharma Company Information
10.14.2 Ipsen Pharma Description and Business Overview
10.14.3 Ipsen Pharma Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ipsen Pharma Hormone Disorder Drug Products Offered
10.14.5 Ipsen Pharma Recent Development
10.15 Ferring B.V
10.15.1 Ferring B.V Company Information
10.15.2 Ferring B.V Description and Business Overview
10.15.3 Ferring B.V Hormone Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Ferring B.V Hormone Disorder Drug Products Offered
10.15.5 Ferring B.V Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hormone Disorder Drug Industry Chain Analysis
11.2 Hormone Disorder Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hormone Disorder Drug Production Mode & Process
11.4 Hormone Disorder Drug Sales and Marketing
11.4.1 Hormone Disorder Drug Sales Channels
11.4.2 Hormone Disorder Drug Distributors
11.5 Hormone Disorder Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Hormone Disorder Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Hormone Disorder Drug Market Trends
Table 3. Hormone Disorder Drug Market Drivers
Table 4. Hormone Disorder Drug Market Challenges
Table 5. Hormone Disorder Drug Market Restraints
Table 6. Global Hormone Disorder Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Hormone Disorder Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Hormone Disorder Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Hormone Disorder Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Hormone Disorder Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Hormone Disorder Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Hormone Disorder Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global Hormone Disorder Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Hormone Disorder Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global Hormone Disorder Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Hormone Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hormone Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Disorder Drug as of 2024)
Table 18. Global Key Manufacturers of Hormone Disorder Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Hormone Disorder Drug, Product Offered and Application
Table 20. Global Key Manufacturers of Hormone Disorder Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Hormone Disorder Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Hormone Disorder Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Hormone Disorder Drug Revenue Share by Players, (2018-2023)
Table 25. India Hormone Disorder Drug Sales by Players, (K Units), (2018-2023)
Table 26. India Hormone Disorder Drug Sales Share by Players, (2018-2023)
Table 27. Global Hormone Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Hormone Disorder Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Hormone Disorder Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Hormone Disorder Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Hormone Disorder Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Hormone Disorder Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Hormone Disorder Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Hormone Disorder Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Hormone Disorder Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Hormone Disorder Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Hormone Disorder Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Hormone Disorder Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Hormone Disorder Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Hormone Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Hormone Disorder Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Hormone Disorder Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Hormone Disorder Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Hormone Disorder Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Teva Pharmaceutical Industries Ltd Company Information
Table 48. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 49. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 51. Teva Pharmaceutical Industries Ltd Recent Development
Table 52. Amneal Pharmaceutical Inc Company Information
Table 53. Amneal Pharmaceutical Inc Description and Business Overview
Table 54. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Amneal Pharmaceutical Inc Hormone Disorder Drug Product
Table 56. Amneal Pharmaceutical Inc Recent Development
Table 57. Mayne Pharma Group Limited Company Information
Table 58. Mayne Pharma Group Limited Description and Business Overview
Table 59. Mayne Pharma Group Limited Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Mayne Pharma Group Limited Hormone Disorder Drug Product
Table 61. Mayne Pharma Group Limited Recent Development
Table 62. Merck KGaA Company Information
Table 63. Merck KGaA Description and Business Overview
Table 64. Merck KGaA Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Merck KGaA Hormone Disorder Drug Product
Table 66. Merck KGaA Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Sanofi Hormone Disorder Drug Product
Table 71. Sanofi Recent Development
Table 72. Sun Pharmaceutical Industries Ltd Company Information
Table 73. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 74. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product
Table 76. Sun Pharmaceutical Industries Ltd Recent Development
Table 77. Novartis AG Company Information
Table 78. Novartis AG Description and Business Overview
Table 79. Novartis AG Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Novartis AG Hormone Disorder Drug Product
Table 81. Novartis AG Recent Development
Table 82. F. Hoffmann-La Roche Ltd Company Information
Table 83. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 84. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product
Table 86. F. Hoffmann-La Roche Ltd Recent Development
Table 87. Abbott Company Information
Table 88. Abbott Description and Business Overview
Table 89. Abbott Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Abbott Hormone Disorder Drug Product
Table 91. Abbott Recent Development
Table 92. PT. Daewoong Pharmaceutical Company Company Information
Table 93. PT. Daewoong Pharmaceutical Company Description and Business Overview
Table 94. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product
Table 96. PT. Daewoong Pharmaceutical Company Recent Development
Table 97. Genentech, Inc Company Information
Table 98. Genentech, Inc Description and Business Overview
Table 99. Genentech, Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Genentech, Inc Hormone Disorder Drug Product
Table 101. Genentech, Inc Recent Development
Table 102. Bausch Health Companies Inc Company Information
Table 103. Bausch Health Companies Inc Description and Business Overview
Table 104. Bausch Health Companies Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Bausch Health Companies Inc Hormone Disorder Drug Product
Table 106. Bausch Health Companies Inc Recent Development
Table 107. Lilly Company Information
Table 108. Lilly Description and Business Overview
Table 109. Lilly Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Lilly Hormone Disorder Drug Product
Table 111. Lilly Recent Development
Table 112. Ipsen Pharma Company Information
Table 113. Ipsen Pharma Description and Business Overview
Table 114. Ipsen Pharma Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Ipsen Pharma Hormone Disorder Drug Product
Table 116. Ipsen Pharma Recent Development
Table 117. Ferring B.V Company Information
Table 118. Ferring B.V Description and Business Overview
Table 119. Ferring B.V Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Ferring B.V Hormone Disorder Drug Product
Table 121. Ferring B.V Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Hormone Disorder Drug Customers List
Table 125. Hormone Disorder Drug Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormone Disorder Drug Product Picture
Figure 2. Global Hormone Disorder Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Hormone Disorder Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global Hormone Disorder Drug Sales 2018-2034 (K Units)
Figure 5. India Hormone Disorder Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Hormone Disorder Drug Market Size 2018-2034 (US$ Million)
Figure 7. India Hormone Disorder Drug Sales 2018-2034 (K Units)
Figure 8. India Hormone Disorder Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Hormone Disorder Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Hormone Disorder Drug Report Years Considered
Figure 11. Product Picture of Growth Hormone Stimulator
Figure 12. Product Picture of Growth Hormone Inhibitor
Figure 13. Global Hormone Disorder Drug Market Share by Type in 2024 & 2034
Figure 14. Global Hormone Disorder Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Hormone Disorder Drug Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 17. Global Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Hormone Disorder Drug Price by Type (2018-2034) & (US$/Unit)
Figure 19. India Hormone Disorder Drug Market Share by Type in 2024 & 2034
Figure 20. India Hormone Disorder Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. India Hormone Disorder Drug Sales Market Share in Value by Type (2018-2034)
Figure 22. India Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 23. India Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 24. India Hormone Disorder Drug Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Dwarfism
Figure 26. Product Picture of Gigantism
Figure 27. Product Picture of Other
Figure 28. Global Hormone Disorder Drug Market Share by Application in 2024 & 2034
Figure 29. Global Hormone Disorder Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Hormone Disorder Drug Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 32. Global Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Hormone Disorder Drug Price by Application (2018-2034) & (US$/Unit)
Figure 34. India Hormone Disorder Drug Market Share by Application in 2024 & 2034
Figure 35. India Hormone Disorder Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. India Hormone Disorder Drug Sales Market Share in Value by Application (2018-2034)
Figure 37. India Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 38. India Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 39. India Hormone Disorder Drug Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Hormone Disorder Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Hormone Disorder Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Hormone Disorder Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Hormone Disorder Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Hormone Disorder Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Hormone Disorder Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 62. China Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 64. China Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Hormone Disorder Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Hormone Disorder Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Hormone Disorder Drug Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Hormone Disorder Drug Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Hormone Disorder Drug Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Hormone Disorder Drug Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Hormone Disorder Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Hormone Disorder Drug Value Chain
Figure 77. Hormone Disorder Drug Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries